These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Abramov Y; Barak V; Nisman B; Schenker JG Fertil Steril; 1997 Feb; 67(2):261-5. PubMed ID: 9022600 [TBL] [Abstract][Full Text] [Related]
3. Soluble ICAM-1 and E-selectin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome. Abramov Y; Schenker JG; Lewin A; Kafka I; Jaffe H; Barak V Fertil Steril; 2001 Jul; 76(1):51-7. PubMed ID: 11438319 [TBL] [Abstract][Full Text] [Related]
4. Dynamic changes of the immunoglobulins in patients with severe ovarian hyperstimulation syndrome: efficacy of a novel treatment using peritoneo-venous shunt. Takamizawa S; Shibahara H; Taneichi A; Obara H; Fujiwara H; Ogawa S; Koike T; Idei S; Sato I Am J Reprod Immunol; 2002 Jan; 47(1):25-30. PubMed ID: 11883746 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-18 levels correlate with severe ovarian hyperstimulation syndrome. Barak V; Elchalal U; Edelstein M; Kalickman I; Lewin A; Abramov Y Fertil Steril; 2004 Aug; 82(2):415-20. PubMed ID: 15302292 [TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of abdominal fluid cytokine levels in ovarian hyperstimulation syndrome (OHSS). Farkas B; Boldizsar F; Bohonyi N; Farkas N; Marczi S; Kovacs GL; Bodis J; Koppan M J Ovarian Res; 2020 Mar; 13(1):25. PubMed ID: 32138790 [TBL] [Abstract][Full Text] [Related]
8. Elevated concentrations of angiogenin in serum and ascitic fluid from patients with severe ovarian hyperstimulation syndrome. Aboulghar MA; Mansour RT; Serour GI; Elhelw BA; Shaarawy M Hum Reprod; 1998 Aug; 13(8):2068-71. PubMed ID: 9756270 [TBL] [Abstract][Full Text] [Related]
9. Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization. Enskog A; Henriksson M; Unander M; Nilsson L; Brännström M Fertil Steril; 1999 May; 71(5):808-14. PubMed ID: 10231037 [TBL] [Abstract][Full Text] [Related]
10. Ovarian origin of plasma and peritoneal fluid prorenin in early pregnancy and in patients with ovarian hyperstimulation syndrome. Itskovitz-Eldor J; Kol S; Lewit N; Sealey JE J Clin Endocrinol Metab; 1997 Feb; 82(2):461-4. PubMed ID: 9024237 [TBL] [Abstract][Full Text] [Related]
11. Levels of soluble vascular cell adhesion molecule-1 and soluble intercellular adhesion molecule-1 are increased in women with ovarian hyperstimulation syndrome. Daniel Y; Geva E; Amit A; Baram A; Englander T; Kupferminc MJ; Fait G; Lessing JB Fertil Steril; 1999 May; 71(5):896-901. PubMed ID: 10231053 [TBL] [Abstract][Full Text] [Related]
12. Severe ovarian hyperstimulation syndrome modifies early maternal serum beta-human chorionic gonadotropin kinetics, but obstetrical and neonatal outcomes are not impacted. Choux C; Barberet J; Ginod P; Cottenet J; Bruno C; Benzénine E; Sagot P; Fauque P Fertil Steril; 2017 Oct; 108(4):650-658.e2. PubMed ID: 28911926 [TBL] [Abstract][Full Text] [Related]
13. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. Rizk B; Aboulghar M; Smitz J; Ron-El R Hum Reprod Update; 1997; 3(3):255-66. PubMed ID: 9322101 [TBL] [Abstract][Full Text] [Related]
14. Increased angiotensin II in ascites during severe ovarian hyperstimulation syndrome: role of early pregnancy and ovarian gonadotropin stimulation. Delbaere A; Bergmann PJ; Gervy-Decoster C; Deschodt-Lanckman M; de Maertelaer V; Staroukine M; Camus M; Englert Y Fertil Steril; 1997 Jun; 67(6):1038-45. PubMed ID: 9176441 [TBL] [Abstract][Full Text] [Related]
15. [Association between renin activity, angiotensin II and ovarian hyperstimulation syndrome]. Fan Y; Chen G Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):647-50. PubMed ID: 11930686 [TBL] [Abstract][Full Text] [Related]
16. Characterization of intraperitoneal cytokines and nitrites in women with severe ovarian hyperstimulation syndrome. Revel A; Barak V; Lavy Y; Anteby E; Abramov Y; Schenker JJ; Amit A; Finci-Yeheskel Z; Mayer M; Simon A; Laufer N; Hurwitz A Fertil Steril; 1996 Jul; 66(1):66-71. PubMed ID: 8752613 [TBL] [Abstract][Full Text] [Related]
17. An ounce of prevention: outpatient management of the ovarian hyperstimulation syndrome. Fluker MR; Copeland JE; Yuzpe AA Fertil Steril; 2000 Apr; 73(4):821-4. PubMed ID: 10731547 [TBL] [Abstract][Full Text] [Related]
18. Assessment of cells in the ascitic fluid of women with ovarian hyperstimulation syndrome: the clinical implications for subsequent ovarian malignancy. Hatzipetros I; Gocze PM; Cziraky K; Kovacs K; Kalman E; Farkas B Reprod Biol Endocrinol; 2013 Sep; 11():91. PubMed ID: 24028152 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin II immunoreactivity is elevated in ascites during severe ovarian hyperstimulation syndrome: implications for pathophysiology and clinical management. Delbaere A; Bergmann PJ; Gervy-Decoster C; Staroukine M; Englert Y Fertil Steril; 1994 Oct; 62(4):731-7. PubMed ID: 7926081 [TBL] [Abstract][Full Text] [Related]
20. Elevated levels of interleukin-6 in ascites and serum from women with ovarian hyperstimulation syndrome. Friedlander MA; Loret de Mola JR; Goldfarb JM Fertil Steril; 1993 Nov; 60(5):826-33. PubMed ID: 8224268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]